SCHEMBL21256017

SCHEMBL21256017

COc1cc2c(cc1OC)CN(C)CCC2

nearest known ligand 0.79

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.79
MAOA P21397 2/20 0.79
SLC6A4 P31645 1/20 0.79
DRD1 P21728 6/20 0.65
DRD4 P21917 5/20 0.65
DRD5 P21918 5/20 0.65
DRD2 P14416 4/20 0.65
DRD3 P35462 4/20 0.65
CHRNA7 P36544 2/20 0.55
PDE4D Q08499 1/20 0.51
ABCB1 P08183 2/20 0.50
CA7 P43166 1/20 0.50
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5525085 0.89 MAOB (1.00) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL30634713 0.89 MAOB (1.00) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL20232219 0.89 MAOB (0.63) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL20214396 0.89 MAOB (0.63) MAOBMAOASLC6A4DRD1DRD4
Hydrochloric Acid SCHEMBL30634715 0.87 MAOB (0.96) MAOBMAOASLC6A4DRD1DRD4
Hydrochloric Acid SCHEMBL20854708 0.87 MAOB (0.96) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL20214588 0.82 MAOA (0.55) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL2915552 0.82 MAOA (0.55) MAOBMAOASLC6A4DRD1DRD4
SCHEMBL9424882 0.82 MAOB (0.73) MAOBMAOASLC6A4DRD1DRD4
Iodide SCHEMBL9425089 0.80 MAOB (0.70) MAOBMAOASLC6A4DRD1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020108688-A1 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE FOR NUCLEAR-MEDICAL IMAGING HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF E.V. (DE) 2020-06-04 WO disclosed
WO-2019154395-A1 TETRAHYDROISOQUINOLINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 中国科学院上海药物研究所 2019-08-15 WO disclosed